Standout Papers

Current applications and future perspective of CRISPR/Cas9 gene editing ... 2020 2026 2022 2024444
  1. Current applications and future perspective of CRISPR/Cas9 gene editing in cancer (2022)
    Siwei Wang, Chao Gao et al. Molecular Cancer
  2. Cancer cell-derived exosomal circUHRF1 induces natural killer cell exhaustion and may cause resistance to anti-PD1 therapy in hepatocellular carcinoma (2020)
    Pengfei Zhang, Chao Gao et al. Molecular Cancer

Immediate Impact

53 standout
Sub-graph 1 of 21

Citing Papers

Nanocarriers address intracellular barriers for efficient drug delivery, overcoming drug resistance, subcellular targeting and controlled release
2024 Standout
Comprehensive review of CRISPR-based gene editing: mechanisms, challenges, and applications in cancer therapy
2024 Standout
1 intermediate paper

Works of Jia‐Cheng Lu being referenced

Current applications and future perspective of CRISPR/Cas9 gene editing in cancer
2022 Standout
Cancer cell-derived exosomal circUHRF1 induces natural killer cell exhaustion and may cause resistance to anti-PD1 therapy in hepatocellular carcinoma
2020 Standout

Author Peers

Author Last Decade Papers Cites
Jia‐Cheng Lu 1439 405 954 35 1.9k
Marc D. Bullock 1190 468 926 30 1.7k
Joshua J. Gruber 1555 355 993 33 2.3k
Sébastien P. Tabruyn 1290 579 762 36 2.3k
Hui Sun Leong 1097 642 717 40 1.8k
Aleksandra Franovic 1236 591 735 36 2.0k
Simone Anfossi 835 639 831 34 1.7k
Xiuchun Qiu 1060 374 885 43 1.9k
Thomas Bertero 1395 445 1133 34 2.3k
Lucas Dennis 1786 457 1234 24 2.4k
Peijing Zhang 1998 905 1002 36 2.7k

All Works

Loading papers...

Rankless by CCL
2026